Your browser doesn't support javascript.
loading
Impact of interventions on the incidence of natural focal diseases during the outbreak of COVID-19 in Jiangsu Province, China.
Cheng, Xiaoqing; Hu, Jianli; Luo, Li; Zhao, Zeyu; Zhang, Nan; Hannah, Mikah Ngwanguong; Rui, Jia; Lin, Shengnan; Zhu, Yuanzhao; Wang, Yao; Yang, Meng; Xu, Jingwen; Liu, Xingchun; Yang, Tianlong; Liu, Weikang; Li, Peihua; Deng, Bin; Li, Zhuoyang; Liu, Chan; Huang, Jiefeng; Peng, Zhihang; Bao, Changjun; Chen, Tianmu.
Afiliación
  • Cheng X; Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Institution of Public Health), Nanjing, 210009, Jiangsu, People's Republic of China.
  • Hu J; Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Institution of Public Health), Nanjing, 210009, Jiangsu, People's Republic of China.
  • Luo L; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Zhao Z; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Zhang N; Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Institution of Public Health), Nanjing, 210009, Jiangsu, People's Republic of China.
  • Hannah MN; Medical College, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Rui J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Lin S; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Zhu Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Wang Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Yang M; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Xu J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Liu X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Yang T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Liu W; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Li P; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Deng B; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Li Z; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Liu C; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Huang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China.
  • Peng Z; School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, People's Republic of China. zhihangpeng@njmu.edu.cn.
  • Bao C; Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Institution of Public Health), Nanjing, 210009, Jiangsu, People's Republic of China. bao2000_cn@163.com.
  • Chen T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China. chentianmu@xmu.edu.cn.
Parasit Vectors ; 14(1): 483, 2021 Sep 19.
Article en En | MEDLINE | ID: mdl-34538265
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Brucelosis / Dengue / COVID-19 / Malaria Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Parasit Vectors Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Brucelosis / Dengue / COVID-19 / Malaria Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Parasit Vectors Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido